Jean-Jacques Fournié

Jean-Jacques Fournié

Laboratoire d’Excellence TOUCAN, France, INSERM UMR1037-Cancer Research Center of Toulouse, Toulouse, France, Université Toulouse III Paul-Sabatier, Toulouse, France, ERL 5294 CNRS, Toulouse, France

Biography
Dr Jean Jacques Fournié is completed his PhD (Biochemistry and Immunology) from Toulouse University and Post-doctoral studies at the Clinical Immunology Research Center of the University of Sydney, Australia. He was a founder of Innate Pharma, a company developing NK cell therapies for cancer. Dr. Fournié is also the Founding Director of Cancer Research Center of Toulouse, an international cancer research laboratory from INSERM, University of Toulouse 3 and CNRS, and leads the research team ‘Innovating Therapeutics Strategies in Lymphomas’ of Laboratoire d’Excellence Toulouse Cancer at Institut Universitaire du Cancer of Toulouse-Oncopole, France.